MassIVE MSV000098391

Partial Public

Intracellular Na+-overload induces a proteomic and metabolomic remodeling of atrial myocytes leading to atrial cardiomyopathy and fibrillation

Description

Aims Targeted therapies for atrial fibrillation (AF), the most common arrhythmia provoking heart failure and stroke, are urgently needed. However, the development of such therapies requires understanding of the cellular mechanisms that culminate in atrial cardiomyopathy (ACM) as a substrate for AF. Like in humans, increased persistent Na+ current leads to the development of ACM and spontaneous episodes of AF in mice. Here, we aim to identify and target the proteomic and metabolomic consequences of intracellular Na+-overload resulting in mitochondrial redox imbalance and contractile dysfunction of atrial myocytes (AMs). Methods and Results Transgenic mice expressing human gain-of-function mutant NaV1.5-F1759A channels in the fully redox-competent C57BL/6N background presented intracellular Na+-overload leading to AM hypertrophy, left atrial (LA) enlargement, contractile dysfunction and episodes of AF at early ages. Hence, we employed mass spectrometry of NaV1.5-F1759A LA myocardium to reveal the proteomic and metabolomic nature of ACM. In total we quantified 3,294 proteins across individual LA samples, of which 440 were differentially regulated in transgenic mice, including functionally relevant enzymes of key metabolic pathways. Metabolomic analyses confirmed changes in glycolytic and anaplerotic substrates, and identified a significant decrease in the cardioprotective antioxidant glutathione. Transgenic expression of the redox biosensor Grx1-roGFP in NaV1.5-F1759A AMs showed an oxidized glutathione redox potential indicative of mitochondrial ROS production upon catecholaminergic stimulation and field-pacing, which was not observed in control cells. Finally, we targeted the decreased expression of the sarcoplasmic reticulum protein junctophilin-2 by transgenic overexpression in NaV1.5-F1759A animals, which recued AM hypertrophy, LA contractility and AF burden in intracellular Na+-overload. Conclusions Atrial cardiomyopathy induced by intracellular Na+-overload in mice is characterized by profound cellular, proteomic and metabolomic changes culminating in mitochondrial redox imbalance and contractile dysfunction, which can be attenuated by restoring atrial junctophilin-2 expression. [doi:10.25345/C5XS5JW00] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: Atrial fibrillation ; atrial cardiomyopathy ; intracellular sodium overload, junctophillin-2 ; proteomic and metabolomic profiling ; reactive oxygen species ; DatasetType:Metabolomics

Contact

Principal Investigators:
(in alphabetical order)
Dr. Prasad Phapale, Leibniz-Institut fuer Analytische Wissenschaften-ISAS-e.V., Germany
Submitting User: Kasarla04
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
 
FTP Download Link (click to copy):

- Dataset Reanalyses


+ Dataset History


Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.